{
    "nctId": "NCT03664895",
    "briefTitle": "Density Lowering Effect of \"OFS Add on to TMX\"(DELFINO Trial)",
    "officialTitle": "Density Lowering Effect of Ovarian Function Suppression in Premenopausal Breast Cancer Patients Who Had no Density Change With One Year of Tamoxifen Treatment",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Invasive",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 224,
    "primaryOutcomeMeasure": "MMG density Reduction",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Premenopausal women, ER+ breast cancer, stage I\\~III, underwent standard treatment including surgery, Planned TMX\n* available MMG density check via Volpara\n\nExclusion Criteria:\n\n* Bilateral breast cancer\n* Prior endocrine therapy\n* Postmenopausal status\n* unavailable MMG density check via volpara before and after TMX",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}